Strengthening Breast Cancer Prevention Through Better Care Coordination

Breast cancer is one of the most common cancers diagnosed in the United States and a leading cause of cancer death among women. It is one reason that CareHarmony prioritizes identifying patients due, and overdue, for mammograms, and helping to ensure patients receive timely screenings.

What makes breast cancer especially challenging, is that it often develops quietly before pain or other obvious symptoms appear. In 2025, the American Cancer Society estimates that 316,950 women in the U.S. will be diagnosed with invasive breast cancer (cancer that spreads into nearby breast tissue), and 42,170 will die from the disease. About 1 in 8 women will develop invasive breast cancer during their lifetime. Beyond its human toll, breast cancer also places a significant financial burden on the healthcare system. According to CDC data, it is the most expensive cancer to treat in the U.S.

What happens when breast cancer is found early

According to the National Cancer Institute’s SEER program, the five-year relative survival rate for breast cancer found at a localized stage is 100 percent. When it is diagnosed after spreading to distant organs, that figure drops to 32.6 percent. Because early-stage breast cancer often causes no noticeable symptoms, routine screening plays a critical role in finding disease when treatment is most effective.

Mammograms can pick up changes before a lump can be felt or any symptoms show up. Breast cancer cannot always be prevented, though some women at higher risk may choose preventive surgery or medication to reduce their risk. Still, early detection is incredibly important. The earlier breast cancer is found, the more likely treatment is to be less intensive and outcomes to be better.

The real gap is follow-through

CareHarmony understands that improving breast cancer screening rates requires more than telling patients to get a mammogram. It means identifying who is due, reaching patients with timely reminders, helping them understand screening recommendations, addressing practical barriers, supporting scheduling, and making sure abnormal findings receive timely diagnostic follow-up.

For example, a patient flagged as overdue for a mammogram may also face transportation or scheduling barriers. Without coordinated follow-up, that screening is delayed. With the right support, it gets scheduled and completed.

CareBlocks™ and closing the gap.

This is exactly the kind of gap CareBlocks™ is designed to address. CareBlocks™ help care teams personalize outreach, spot barriers earlier, and get a clearer picture of what is actually helping patients follow through. In breast cancer screening, success depends on consistently closing those gaps across outreach, access, and follow-up. More often, screening falls through because of small breakdowns along the way, whether that is missed outreach, scheduling challenges, access issues, or delays in follow-up.

Our CareBlocks also help to identify potential barriers to care a patient may face, including lack of insurance, lack of transportation, and food insecurity. Our trained care coordinators and social workers help to address those barriers by partnering with community groups to ensure patients can access the care being recommended to them.

At CareHarmony, we know many patients who need support staying on track with preventive services, including cancer screenings, are also managing chronic conditions, competing priorities, and barriers that can delay care. That is why coordinated support between visits matters. When care teams help patients work through scheduling, access, and follow-up, preventive care is more likely to happen.

Turning early detection into measurable impact

Breast cancer remains common, serious, and costly, but it is also one of the clearest examples of how early detection and coordinated care can improve outcomes. The tools already exist. Screening recommendations are established. The remaining challenge is implementation: making sure eligible patients are identified, supported, screened, and guided to next steps without unnecessary delay.

There is evidence that patient navigation and barrier-reduction strategies improve screening completion. The Community Preventive Services Task Force recommends approaches that engage community health workers to increase mammography screening and reduce structural barriers to care, particularly in underserved communities.

For health systems, provider groups, and value-based care organizations, that makes breast cancer screening more than a clinical priority. It is also an operational opportunity. The organizations that improve completion rates are often the ones that treat screening not as a one-time reminder, but as a coordinated process built around personalization, barrier reduction, and follow-through.

At CareHarmony, we believe that better preventive care performance starts with better follow-through. Coordinated support between visits, combined with more personalized and measurable interventions through CareBlocks™, can help organizations close the gap between eligibility and action. What ultimately saves lives is not just having the right guidelines. It is making sure those guidelines turn into completed care.

Early detection saves lives, but only when it actually happens. The difference is not in the guidelines. It is in the follow-through.

Organizations that want to improve preventive care should start by looking at where screening is falling off, then strengthen the process so more patients move from being eligible to actually getting screened. Clearer follow-up, more thoughtful outreach, and a smoother path through care all make a difference. That is how early detection becomes something real, not just something recommended.

Learn more about CareBlocks™

Common questions about breast cancer

Q: When should I start breast cancer screening?
A: The U.S. Preventive Services Task Force recommends screening mammography every other year beginning at age 40 for women at average risk and continuing through age 74. Women at higher risk may need a different screening plan based on clinical guidance.

Q: Why should I get screened if I feel fine?
A: Early-stage breast cancer often causes no symptoms. Mammograms can detect abnormalities before they are felt, helping identify cancer at a stage when treatment is more effective and outcomes are significantly better.

Q: If I do not have a family history, do I still need screening?
A: Yes. Many people diagnosed with breast cancer do not have a known family history. Family history is only one part of risk, which is why routine screening is recommended even in the absence of symptoms or known genetic risk.